Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
Research News
Donate Now
Parkinson's Research

Research News

Read the latest developments, reporting and analysis from the world of Parkinson's research, including progress made in studies, tools and collaborations funded by The Michael J. Fox Foundation.
  • Update on Alpha-synuclein Therapies in Clinical Trials

    Research Roundup: Studies Offer More Shots on Goal Toward Cures

    We share four research studies looking for volunteers — people with and without Parkinson’s disease.
    Learn more
  • Fox Trial Finder Expands to Accelerate Research in Atypical Parkinsonism

    What about Adenosine? Another Target for Therapies and Perhaps Lowering Risk

    Targeting the adenosine brain chemical pathway helps improve symptoms during “off” episodes and may play a role in lowering Parkinson’s risk.
    Learn more
  • Testing Materials

    What We Fund: $21 Million to Ease Symptoms, Profile Genes and Test for the “Parkinson’s Scent"

    In this bimonthly report, we review some of the 46 grants totaling more than $21 million we awarded in June and July.
    Learn more
  • Ogden 2015_lab testing.jpg

    Major Deal Pushes Parkinson’s Vaccine Further in Testing

    AFFiRiS and AC Immune, both Michael J. Fox Foundation grantees, announced a partnership that will advance a vaccine to lower levels of Parkinson’s protein alpha-synuclein.
    Learn more
  • Dr. AJ Headshot 4x5sm-Speak.jpg

    MJFF Research Fellow Works to ‘Untangle the Roots’ of Medical Mistrust and Clinical Trial Participation

    To help understand the complex barriers to research participation, we spoke with Michael J. Fox Foundation Research Fellow — a partnership with the Community Access, Recruitment and Engagement (CARE)…
    Learn more
  • The State of the Science of Parkinson's Research

    What We Fund: Expanding Our Landmark Study and Studying a New Parkinson’s Gene

    Our bimonthly report shares highlights from 36 new grants totaling $6.3 million in April and May including efforts to make our PPMI study more inclusive and to study a gene that may work with LRRK2…
    Learn more
  • Ogden_Lab board.jpg

    What Does the New Alzheimer’s Drug Mean for People with Parkinson’s?

    Learn what the recent approval of a new Alzheimer’s drug — the first in almost two decades — might mean for you and your loved one.
    Learn more
Close-up portrait

Join the Study that's Changing Everything

The Parkinson's Progression Markers Initiative is changing how patients, families, doctors and scientists think about brain disease. Now it needs you.

Get Started
Michael J. Fox in blue sweater posing for the camera.

Patients First

Our Foundation exists for one reason: to speed breakthroughs patients can feel in their everyday lives.

Read Our Promise
"The question most frequently asked of us is: 'How close are we to a cure for Parkinson’s disease?' With over $800 million in Parkinson's research funded to date, the simplest answer is: closer than ever."
Todd Sherer, PhD
Todd Sherer, PhD Chief Mission Officer
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.
Here. Until Parkinson's isn't.
Join us as we work to find a cure for the 6 million people worldwide living with Parkinson's.
 
 
 
 
Month
Day
Year